The largest database of trusted experimental protocols

134 protocols using okadaic acid

1

Worm Culture and Okadaic Acid Treatment

Check if the same lab product or an alternative is used in the 5 most similar protocols
All strains were grown at 20 °C under standard procedures according to Brenner [34 (link)] and fed Escherichia coli OP50-1 culture for 28–30 hours from the L1 stage. After this time, the worms were moved to NGM control plates (2 g NaCl, 3 g KH2PO4, 0.5 g K2HPO4, 0.0085 g/mL cholesterol diluted in 1 mL of absolute ethanol, 30 g Bactoagar, and H2O up to 1 L) or to glucose-supplemented plates (100 mM) previously seeded with E. coli OP50-1 and supplemented with 49 μM of 5-fluoro-2′-deoxyuridine (FUDR, Sigma-Aldrich). For okadaic acid treatment, nematodes were placed on NGM plates containing 100 mM glucose, and then, okadaic acid (Sigma-Aldrich) was added to these plates to a final concentration of 30, 60, 120 and 240 nM and allowed to dry for approximately 20 minutes. Then, E. coli OP50-1 was seeded onto each plate. Worms were exposed for 24 hours to this condition. Three independent experiments were performed with more than 30 worms for each experimental condition.
+ Open protocol
+ Expand
2

Selective Protein Knockdown in Cell Lines

Check if the same lab product or an alternative is used in the 5 most similar protocols
NIH3T3, HEK293T, PC6-3, and A549 cells were cultured and transfected as described (Strack et al., 2004 (link); Jin et al., 2010 (link)). siRNA-mediated knockdown of endogenous B56ε in NIH3T3 or knockdown of endogenous Fam13a in A549 cells was performed using Lipofectamine 2000 transfection reagent (Life Technologies, Gaithersburg, MD). The sequences for the sense and antisense strands of siRNAs are as follows: siGFP, 5′-gcaagcugacccugaaguucuu-3′; 5′-gaacuucagggucagcuugcuu-3′. siB56ε, 5′-ccuagugacagcaaugaauuu-3′; 5′ -auucauugcugucacuagguu-3′. siFam13a, 5′-ggagaacucuuagaaagaauu-3′; 5′-uucuuucuaagaguucuccuu-3′. Knockdown of B56s in PC6-3 cells was carried out as described (Strack et al., 2004 (link); Jin et al., 2011 (link)). For PP2A and Akt inhibition studies, NIH3T3 cells were treated with okadaic acid (50 nM, #O7885; Sigma-Aldrich, St. Louis, MO) and/or wortmannin (2 μM, #W1628; Sigma-Aldrich) or LY294002 (#L9908; Sigma-Aldrich) in DMEM supplemented with 0.5% bovine calf serum 1 d after transfection and harvested 15 h after drug administration. For leptomycin B treatment, NIH3T3 cells were exposed to 5 ng/ml leptomycin B (#L2913; Sigma-Aldrich) and/or 50 nM okadaic acid for 15 h before fixation.
+ Open protocol
+ Expand
3

Analyzing T Cell Death Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
T cell death was analyzed by flow cytometric staining for Annexin V (BD Bioscience) and 7-AAD (BD Bioscience) in different conditions. For in vitro activation, cells from the spleen or LNs were activated either with anti-CD3/CD28 signaling or with PMA/ionomycin stimulation. For treatment with Z-VAD-FMK (R&D Systems), BHA (Sigma), or okadaic acid (sigma), cells from LNs were pretreated with indicated concentrations of Z-VAD-ZMK, BHA or okadaic acid for 30min, then stimulated with PMA(10ng)/Ionomycin (1000ng) for 6h. For assessment of cell death in vivo, cells in the spleen or tumors from WT and KO mice were directly stained for Annexin V and 7-AAD without any in vitro stimulation.
+ Open protocol
+ Expand
4

Synthesis and Evaluation of SAB298 Compound

Check if the same lab product or an alternative is used in the 5 most similar protocols
SAB298 was synthesized in six steps according to the procedures outlined in WO 2018/049127 patent application (examples 3, 15, 17, 44, 45 and 46). Its activity was compared to UM-164 (Sigma-Aldrich, St. Louis, MO), dasatinib (BMS 354825), bosutinib (SKI-606), saracatinib, SU6656, sapitinib (AZD8931), ralimetinib (LY2228820), dacomitinib, lifirafenib (BGB-283) and SCH772984 (all from Selleckchem, Houston, TX), okadaic acid (MilliporeSigma, St. Louis, MO), trametinib (LC Laboratories, Woburn), and imatinib (NCI).
+ Open protocol
+ Expand
5

Immunofluorescence and Cell Culture Protocols

Check if the same lab product or an alternative is used in the 5 most similar protocols
Rabbit pAb to human MxA (H-285) (ab-95926) was purchased from Abcam Inc. (Cambridge, MA, USA); Mouse mAb to the VSV nucleocapsid (N) designated 10G4 was a gift from Dr. Douglas S. Lyles (Wake Forest School of Medicine, NC, USA). Rabbit mAb to glyceraldehyde-3-phosphate dehydrogenase (GAPDH; 14C10; number 2118) was obtained from Cell Signaling (Danvers, MA, USA). Respective AlexaFluor 488- and AlexaFluor 594-tagged secondary donkey antibodies to rabbit (A-11008 and A-11012) or mouse (A-21202 and A-21203) IgG were from Invitrogen Molecular Probes (Eugene, OR, USA).
Cyclosporin A (CsA) was purchased from APExBIO (Houston, TX, USA); calcien-AM, calyculin-A, okadaic acid, and tetraethylammonium chloride (TEA) (a “nonselective” K-channel blocker [31 (link)]) were purchased from Millipore-Sigma (St. Louis, MO, USA).
Lipton’s black tea, pre-ground Colombian coffee, and Propel were purchased from ShopRite supermarket (Elmsford, NY, USA). Tea was brewed by soaking one tea bag in one cup of boiling water (8 oz) for 2 min; coffee was brewed in a drip percolator (2 tablespoons coffee grounds per one cup of water). Drinking water was used from a water fountain in the laboratory. All beverages were equilibrated at 37 °C before use in cell culture experiments.
+ Open protocol
+ Expand
6

Curcumin Characterization and Applications

Check if the same lab product or an alternative is used in the 5 most similar protocols
The chemical content of turmeric-derived curcumin (#218580100, Fisher
Scientific) was verified using standard methods (see below), with assayed
content 96.5% curcuminoids by weight, comprised of 80.6% curcumin with lesser
amounts of demethoxycurcumin [13.5%] and bisdemethoxycurcumin [2.4%])) [35 (link),36 (link)], and stock solutions prepared in DMSO. A non-oxidizable curcumin
analog, diacetyl curcumin (DAC), was synthesized as previously described [34 (link),37 (link)]. Cells were stimulated, as indicated, with recombinant human
TGFβ1 (#240-B, R&D Systems). N-acetylcysteine (NAC, #A1540914) and
nystatin (#J6048606) were purchased from Alfa Aesar. Cycloheximide (CHX,
#C7698), (#SML1169), okadaic acid (OA, #459620), chloroquine (CQ, #C6628), and
MG132 (#474791) were purchased from Millipore-Sigma. The MAPK inhibitors
SP600125 (#S1077) and SB202190 (#S1460) were purchased from Selleckchem.
Mini-PROTEAN TGX-PAGE gels (#4568046) were purchased from BioRad and PVDF
membranes (#IPFL0010) from Millipore.
+ Open protocol
+ Expand
7

Compound Library Preparation Protocol

Check if the same lab product or an alternative is used in the 5 most similar protocols
All the compounds, coming from our in-house MBC library,32 (link) were prepared with a stock concentration of 25 or 10 mM in DMSO. The final % of DMSO in cell culture was not higher than 0.1%. Bafilomycin A1 (Baf1) (Enzo Life Sciences – BML-1100–0100) and okadaic acid (OA) (Sigma – O9381) were also prepared in DMSO. Deferiprone (DFP) (Sigma − 379409) was dissolved in water. Carbonyl cyanide-p-trifluoromethoxyphenylhydrazone (FCCP) (Sigma, C2920) was dissolved in ethanol.
+ Open protocol
+ Expand
8

Cytoskeletal Dynamics in Hantavirus Infection

Check if the same lab product or an alternative is used in the 5 most similar protocols
Vero E6 were infected with TULV at a MOI of 0.5 in a 6-well plate. Infected cells were harvested for immunofluorescence and q-RT PCR analysis at 30 days post infection. Prior to harvesting, the cells were treated with the following cytoskeletal inhibitors; 17 μM nocodazole (Sigma-Aldrich, St. Louis, MO, USA) for 60 min and 400 nM okadaic acid (OA) (Sigma-Aldrich) for 30, 60 or 90 min. Infected Vero E6 cells treated with OA were also recovered by removing the inhibitor and incubating overnight with fresh media before harvesting. Mock treatments were carried out using an equal volume of solvent (dimethyl sulfoxide (DMSO)/ethanol).
+ Open protocol
+ Expand
9

Maduramicin ammonium cytotoxicity mechanism

Check if the same lab product or an alternative is used in the 5 most similar protocols
Maduramicin ammonium (molecular weight = 934.16, purity > 97%, by HPLC) was purchased from Santa Cruz Biotechnology (Santa Cruz, CA, USA), dissolved in dimethyl sulfoxide (DMSO) to prepare a stock solution (5 mg/ml), aliquoted and stored at –20°C. Dulbecco’s modified Eagle’s medium (DMEM) and 0.05% trypsin-EDTA were obtained from Mediatech (Manassas, VA, USA). Fetal bovine serum (FBS) was from Atlanta Biologicals (Lawrenceville, GA, USA). Okadaic acid (OA) was from Sigma (Saint Louis, MO, USA). CellTiter 96® AQueous one solution cell proliferation analysis kit was from Promega (Madison, WI, USA). Enhanced chemiluminescence solution was from Perkin-Elmer Life Science (Boston, MA, USA). The following antibodies were used: ERK2, JNK, phosphorylated-JNK (p-JNK) (Thr183/Tyr185), c-Jun, p-c-Jun (Ser63), p38, p-PP2A (Tyr307), demethylated-PP2A (De-PP2A), HA and GAPDH (Santa Cruz Biotechnology, Santa Cruz, CA, USA), p-ERK1/2 (Thr202/Tyr204) and p-p38 (Thr180/Tyr182) (Cell signaling technology, Beverly, MA, USA), PP2Ac, PP2A-A, PP2A-B and methylated-PP2A (Me-PP2A) (Upstate biotechnology, Waltham, MA, USA), PP5 (BD transduction laboratories, San Jose, CA, USA), FLAG (Sigma, Saint Louis, MO, USA), goat anti-mouse IgG-horseradish peroxidase and goat anti-rabbit IgG-horseradish peroxidase (Pierce, Rockford, IL, USA).
+ Open protocol
+ Expand
10

Okadaic Acid Nuclear Import Inhibition

Check if the same lab product or an alternative is used in the 5 most similar protocols
Okadaic acid (OA) (Sigma), a inhibitor which blocks the nuclear import of HDAC4 [26 (link),27 (link)], was prepared as a 10-μM stock in dimethyl sulfoxide (DMSO, Sigma) and added to culture medium 2 hours before CTS at the final concentration of 10 nM [27 (link),28 (link)].
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!